01476nas a2200289 4500000000100000008004100001260001700042653003200059653001100091653003000102653003200132653001300164653001200177100001500189700001100204700001700215700001500232700001300247700001200260700001600272245004800288300001100336490000700347050003200354520078600386022001401172 1984 d c1984 Oct-Dec10aEvaluation Studies as Topic10aHumans10aHypersensitivity, Delayed10aHypersensitivity, Immediate10aLepromin10aleprosy1 aSengupta U1 aRamu G1 aRevankar C R1 aGanapati R1 aGarg B R1 aGhosh M1 aDesikan K V00aEvaluation of standard Dharmendra lepromin. a748-530 v56 aInfolep Library - available3 a

Dharmendra lepromin standardized at Central JALMA Institute for Leprosy (CJIL) by bacterial counts was used by different observers in four different Centres to assess the early and late reactions. Patients taken into the study were from different ethnic groups in different regions of the country. Comparable skin reactions were found at the Bombay Leprosy Project (BLP), Bombay and at the CJIL, Agra wherein a large number of patients were taken in the study. Similarly, when a smaller number of patients were taken in the study at the Base Hospital (BH), Barrackpore, and at the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, the skin reactions noted in patients at these Centres were again found to be statistically comparable.

 a0254-9395